FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   UNGER MARC 2. Date of Event Requiring Statement (Month/Day/Year) 08/06/2015 3. Issuer Name and Ticker or Trading Symbol FLUIDIGM CORP [FLDM] (Last) (First) (Middle) FLUIDIGM CORPORATION, 7000 SHORELINE COURT SUITE 100 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) See Remarks 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) SOUTH SAN FRANCISCO, CA 94080 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 2,401 D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	  (1)	08/26/2020	Common Stock	934	$ 4.4461	D	Â
Employee Stock Option (Right to Buy)	  (1)	01/04/2021	Common Stock	4,850	$ 8.3732	D	Â
Employee Stock Option (Right to Buy)	  (1)	01/04/2021	Common Stock	270	$ 8.3732	D	Â
Employee Stock Option (Right to Buy)	  (2)	03/05/2022	Common Stock	20,000	$ 14.55	D	Â
Employee Stock Option (Right to Buy)	  (3)	02/15/2023	Common Stock	55,000	$ 16.73	D	Â
Employee Stock Option (Right to Buy)	  (4)	03/14/2024	Common Stock	14,000	$ 47.55	D	Â
Employee Stock Option (Right to Buy)	  (4)	03/14/2024	Common Stock	12,000	$ 47.55	D	Â
Employee Stock Option (Right to Buy)	  (5)	03/12/2025	Common Stock	12,000	$ 41.14	D	Â
Restricted Stock Units	  (6)	  (7)	Common Stock	3,734	$ 0	D	Â
Restricted Stock Units	  (8)	  (7)	Common Stock	3,200	$ 0	D	Â
Restricted Stock Units	  (9)	  (7)	Common Stock	4,401	$ 0	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
UNGER MARC FLUIDIGM CORPORATION 7000 SHORELINE COURT SUITE 100 SOUTH SAN FRANCISCO, CA 94080	Â	Â	  See Remarks	Â

Signatures

Valerie Barnett, attorney-in-fact		08/17/2015
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The Option is fully vested.
(2)	1/48th of the shares subject to the Option vested on January 1, 2012 and 1/48th of the shares subject to the Option vested on February 1, 2012 and each month thereafter, such that the Option will be fully vested on January 1, 2016.
(3)	1/48th of the shares subject to the Option vested on January 1, 2013 and 1/48th of the shares subject to the Option vested on February 1, 2013 and each month thereafter, such that the Option will be fully vested on January 1, 2017.
(4)	1/48th of the shares subject to the Option vested on January 1, 2014 and 1/48th of the shares subject to the Option vested on February 1, 2014 and each month thereafter, such that the Option will be fully vested on January 1, 2018.
(5)	2/48th of the shares subject to the Option vested on March 12, 2015 and 1/48th of the shares subject to the Option vest on April 1, 2015 and each month thereafter, such that the Option will be fully vested on January 1, 2019.
(6)	On March 14, 2014, the Reporting Person was originally granted 5,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2014, and 3/48th of the total number of shares underlying the Restricted Stock Units granted vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
(7)	Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
(8)	On March 14, 2014, the Reporting Person was originally granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2014, and 3/48th of the total number of shares underlying the Restricted Stock Units granted vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
(9)	On March 12, 2015, the Reporting Person was originally granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
  Remarks: Sr. VP, R&D & Single-Cell Biology Marketing Exhibit List Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.